There are currently 7 active clinical trials seeking participants for Dry Eye research studies. The states with the highest number of trials for Dry Eye participants are California, Florida, Massachusetts and Tennessee.
A Study in the Treatment of Mild to Moderate Dry Eye Disease Comparing Saline to TTAX03.
NCT06780306
Recruiting
The purpose of this randomized, controlled, multicenter study is to evaluate the safety and efficacy of TTAX03 in participants with mild to moderate DED. The primary question it aims to answer is if TTAX03 is safe. The secondary is the effectiveness. Researchers will compare 10mg of TTAX03 reconstituted in 150, 300, or 600 uL saline to the saline control group to look at effectiveness. Participants will be randomized to a treatment group one time and be evaluated at 5 different study visits.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/28/2025
Locations: Eye Associates of North Jersey, Dover, New Jersey +3 locations
Conditions: Dry Eye, Dry Eye Disease (DED), Dry Eye Disease With Severe Keratitis
Register for Updates
Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests
NCT04125134
Recruiting
This is a single site, prospective, cross-sectional, controlled clinical study on a total of 66 subjects. The subjects are divided into two groups: Hypertonic Saline Non-Responders (33 subjects) and Hypertonic Saline Responders (33 subjects). After completion of questionnaires, the subjects will undergo Dry Eye Disease testing and functional nerve testing. Subjects who qualify will be dispensed 4 weeks of preservative free artificial tears and instructed to instill one drop into each eye twice d... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/24/2025
Locations: Tufts Medical Center-New England Eye Center, Boston, Massachusetts
Conditions: Dry Eye
Register for Updates
The THINK Study Incidence of Neurotrophic Keratopathy)
NCT06482164
Recruiting
The study purpose is to evaluate corneal sensitivity in patients that have Stage 1 Neurotrphic Keratopathy (NK). Identifying patients with Stage 1 NK, may predict those who will in the future require rhNGF for optimal visual performance.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/25/2024
Locations: Harvard Eye Associates, Laguna Beach, California
Conditions: Dry Eye
Register for Updates
A Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye
NCT06296966
Recruiting
The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to placebo in the treatment of dry eye.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/05/2024
Locations: Vanda Investigational Site, Andover, Massachusetts
Conditions: Dry Eye
Register for Updates
Evaluating Impact of Systane iLux on Dryness Symptoms and Wearing Time in Contact Lens Users
NCT05306561
Recruiting
To evaluate dry eye symptoms and contact lens wearing times after a single iLux treatment by evaluating change from baseline in OSDI scores, subjective CLDEQ8 and CL wearing time questionnaires, and meibomian gland secretion scores.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/14/2023
Locations: Periman Eye Institute, Seattle, Washington
Conditions: Meibomian Gland Dysfunction, Dry Eye
Register for Updates
TearCare System to Treat Dry Eye Disease
NCT03857919
Recruiting
In this study, the TearCare System will be compared with the LipiFlow Thermal Pulsation System in patients with dry eye disease. The objective is to demonstrate that the TearCare System is safe and effective in relieving the signs and symptoms of dry eye disease. NOTE: All sites have been selected for this study. We are not seeking additional sites at this time.
Gender:
ALL
Ages:
22 years and above
Trial Updated:
09/17/2019
Locations: Center for Excellence in Eye Care, Miami, Florida
Conditions: Dry Eye, Meibomian Gland Dysfunction
Register for Updates
Study of the TearCare System in Dry Eye Disease
NCT03588624
Recruiting
This study is being conducted to evaluate the short-term (1 month) safety and effectiveness of a single TearCare procedure to treat adult patients with dry eye disease. NOTE: All sites have been selected for this study.
Gender:
ALL
Ages:
22 years and above
Trial Updated:
08/15/2018
Locations: Eye Research Institute, Newport Beach, California +1 locations
Conditions: Dry Eye
Register for Updates